 This study is SADSingle Ascending DoseMADMultiple Ascending Dose study to Explore the Tolerability, Safety and PharmacokineticsPharmacodynamics of GC1102 Recombinant Hepatitis B Human Immunoglobulin in Chronic Hepatitis B Patients. 